NTP42   Click here for help

GtoPdb Ligand ID: 11537

Synonyms: NTP-42
Compound class: Synthetic organic
Comment: NTP42 is a thromboxane receptor antagonist [3-4]. Its chemical structure is claimed in patent WO2016203314A1 [2]. TP signalling has demonstrable importance in the development and progression of pulmonary arterial hypertension (PAH). ATXA Therapeutics are progressing NTP42 into early stage clinical evaluation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 125.9
Molecular weight 515.13
XLogP 5.47
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F
Isomeric SMILES N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F
InChI InChI=1S/C25H23F2N3O5S/c1-25(2,3)29-24(31)30-36(32,33)22-13-16(15-28)7-12-21(22)34-20-6-4-5-18(14-20)17-8-10-19(11-9-17)35-23(26)27/h4-14,23H,1-3H3,(H2,29,30,31)
InChI Key RIIKDGPBTPECSW-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
AXTA Therapuetics have secured orphan designation from the EMA (in 2018 [1]) and FDA for NTP42 as a PAH treatment.